HK1058145A1 - Method of making particles for use in a pharmaceutical composition - Google Patents
Method of making particles for use in a pharmaceutical compositionInfo
- Publication number
- HK1058145A1 HK1058145A1 HK04100843.5A HK04100843A HK1058145A1 HK 1058145 A1 HK1058145 A1 HK 1058145A1 HK 04100843 A HK04100843 A HK 04100843A HK 1058145 A1 HK1058145 A1 HK 1058145A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- pharmaceutical composition
- particles
- making particles
- relates
- composite active
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/5115—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/501—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5015—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5089—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Otolaryngology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Emergency Medicine (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Nanotechnology (AREA)
- Optics & Photonics (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0029261A GB0029261D0 (en) | 2000-11-30 | 2000-11-30 | Method of making particles for use in a pharmaceutical composition |
GB0030946A GB0030946D0 (en) | 2000-12-19 | 2000-12-19 | Method of making particles for use in a pharmaceutical composition |
PCT/GB2001/001606 WO2001076575A2 (en) | 2000-04-07 | 2001-04-09 | The treatment of respiratory diseases |
GB0124010A GB0124010D0 (en) | 2001-10-05 | 2001-10-05 | Pharmaceutical compositions for inhalation |
PCT/GB2001/005315 WO2002043701A2 (en) | 2000-11-30 | 2001-11-30 | Method of making particles for use in a pharmaceutical composition |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1058145A1 true HK1058145A1 (en) | 2004-05-07 |
Family
ID=31891809
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK04100843.5A HK1058145A1 (en) | 2000-11-30 | 2004-02-09 | Method of making particles for use in a pharmaceutical composition |
HK11108528.1A HK1154347A1 (zh) | 2000-11-30 | 2011-08-15 | 製備用於藥物組合物的顆粒的方法 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK11108528.1A HK1154347A1 (zh) | 2000-11-30 | 2011-08-15 | 製備用於藥物組合物的顆粒的方法 |
Country Status (9)
Country | Link |
---|---|
US (11) | US7736670B2 (de) |
EP (6) | EP2283818B1 (de) |
JP (1) | JP5192447B2 (de) |
AT (2) | ATE382335T1 (de) |
CY (2) | CY1112338T1 (de) |
DK (3) | DK1337240T4 (de) |
ES (3) | ES2474199T3 (de) |
HK (2) | HK1058145A1 (de) |
PT (4) | PT1337240E (de) |
Families Citing this family (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9515182D0 (en) * | 1995-07-24 | 1995-09-20 | Co Ordinated Drug Dev | Improvements in and relating to powders for use in dry powder inhalers |
GB0009469D0 (en) | 2000-04-17 | 2000-06-07 | Vectura Ltd | Improvements in or relating to formalities for use in inhaler devices |
CN100551358C (zh) | 2000-06-27 | 2009-10-21 | 维克多瑞有限公司 | 用于药物组合物的颗粒的制备方法 |
DK1337240T4 (en) * | 2000-11-30 | 2015-01-05 | Vectura Ltd | A process for the preparation of particles for use in a pharmaceutical composition |
ATE446085T1 (de) * | 2000-11-30 | 2009-11-15 | Vectura Ltd | Partikel zur verwendung in einer pharmazeutischen zusammensetzung |
US20040121003A1 (en) * | 2002-12-19 | 2004-06-24 | Acusphere, Inc. | Methods for making pharmaceutical formulations comprising deagglomerated microparticles |
US20060147389A1 (en) * | 2004-04-14 | 2006-07-06 | Vectura Ltd. | Devices and pharmaceutical compositions for enhancing dosing efficiency |
US20120321717A1 (en) * | 2003-04-14 | 2012-12-20 | Vectura Ltd. | Devices and pharmaceutical compositions for enhancing dosing efficiency |
GB0327723D0 (en) | 2003-09-15 | 2003-12-31 | Vectura Ltd | Pharmaceutical compositions |
GB0321607D0 (en) * | 2003-09-15 | 2003-10-15 | Vectura Ltd | Manufacture of pharmaceutical compositions |
US20050056958A1 (en) * | 2003-09-16 | 2005-03-17 | Eastman Kodak Company | Forming homogeneous mixtures of organic materials for physical vapor deposition using dry mixing |
GB0409703D0 (en) * | 2004-04-30 | 2004-06-02 | Vectura Ltd | Pharmaceutical compositions |
GB0418791D0 (en) * | 2004-08-23 | 2004-09-22 | Glaxo Group Ltd | Novel process |
GB0425758D0 (en) * | 2004-11-23 | 2004-12-22 | Vectura Ltd | Preparation of pharmaceutical compositions |
GB0426301D0 (en) * | 2004-11-30 | 2004-12-29 | Vectura Ltd | Pharmaceutical formulations |
JP5288791B2 (ja) * | 2005-01-28 | 2013-09-11 | 武田薬品工業株式会社 | 難水溶性物質含有微細化組成物 |
US7951419B2 (en) * | 2005-07-21 | 2011-05-31 | Multisorb Technologies, Inc. | Dry-coated oxygen-scavenging particles and methods of making them |
EP1978933A2 (de) * | 2005-12-15 | 2008-10-15 | Acusphere, Inc. | Verfahren zur herstellung von pharmazeutischen formulierungen auf teilchenbasis zur oralen verabreichung |
CA2653384C (en) | 2006-06-30 | 2017-03-14 | Iceutica Pty Ltd | Methods for the preparation of biologically active compounds in nanoparticulate form |
US8969402B2 (en) | 2006-11-15 | 2015-03-03 | Steven A. Rich | Combined acetylcholinesterase inhibitor and quaternary ammonium antimuscarinic therapy to alter progression of cognitive diseases |
US7883039B2 (en) * | 2007-02-27 | 2011-02-08 | Collette Nv | Continuous granulating and drying apparatus including measurement units |
GB0712316D0 (en) * | 2007-06-26 | 2007-08-01 | Entripneur Ltd | A novel powder and its method of manufacture |
ES2460576T3 (es) * | 2007-12-13 | 2014-05-13 | Novartis Ag | Procedimiento para preparar una sustancia farmacológica en partículas y cristalina |
CN101896162B (zh) * | 2007-12-13 | 2013-06-05 | 诺瓦提斯公司 | 有机化合物 |
WO2010014846A1 (en) * | 2008-07-30 | 2010-02-04 | T & T Enterprises Inc. | Antioxidant additive |
EP3578169B1 (de) | 2009-02-26 | 2024-06-26 | Glaxo Group Limited | Pharmazeutische formulierungen enthaltend 4-{(1 r)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol |
PT2410981T (pt) | 2009-03-26 | 2017-05-25 | Pulmatrix Inc | Formulações em pó seco e métodos para tratar doenças pulmonares |
BRPI1014275B8 (pt) | 2009-04-24 | 2021-05-25 | Iceutica Pty Ltd | composição que compreende partículas de indometacina dispersas em pelo menos dois materiais de moagem parcialmente moídos |
MY159098A (en) * | 2009-04-24 | 2016-12-15 | Iceutica Pty Ltd | Production of encapsulated nanoparticles at high volume fractions |
KR101979164B1 (ko) * | 2009-04-24 | 2019-05-15 | 아이슈티카 피티와이 리미티드 | 캅셀화된 나노입자의 상업적 규모의 생산 |
LT2435025T (lt) | 2009-05-29 | 2016-09-26 | Pearl Therapeutics, Inc. | Veikliosios medžiagos tiekimas per kvėpavimo takus |
US8815258B2 (en) | 2009-05-29 | 2014-08-26 | Pearl Therapeutics, Inc. | Compositions, methods and systems for respiratory delivery of two or more active agents |
GB0921075D0 (en) | 2009-12-01 | 2010-01-13 | Glaxo Group Ltd | Novel combination of the therapeutic agents |
CA2789674A1 (en) * | 2010-03-09 | 2011-09-15 | Stc.Unm | Apparatuses and methods for microparticle dry coating of surfaces |
EP2448571B1 (de) | 2010-08-30 | 2013-06-12 | Pulmatrix, Inc. | Einatembares trockenpulver mit calciumlactat, natriumchlorid und leukin |
CN105640925B (zh) * | 2010-08-30 | 2019-08-16 | 普马特里克斯营业公司 | 干燥粉末配方及用于治疗肺部疾病的方法 |
EP2621488B1 (de) | 2010-09-29 | 2018-11-07 | Pulmatrix Operating Company, Inc. | Kationische trockenpulver |
AU2011308865B2 (en) | 2010-09-29 | 2017-01-05 | Pulmatrix, Inc. | Monovalent metal cation dry powders for inhalation |
SG10201703243QA (en) * | 2012-02-28 | 2017-06-29 | Iceutica Holdings Inc | Inhalable pharmaceutical compositions |
NZ629722A (en) | 2012-02-29 | 2017-03-31 | Pulmatrix Operating Co Inc | Inhalable dry powders |
MX366744B (es) * | 2012-03-23 | 2019-06-28 | Copamex S A De C V | Composición super-hidrofóbica, su preparación y papel que presenta super-hidrofobicidad. |
KR20140147891A (ko) | 2012-04-13 | 2014-12-30 | 글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 | 응집체 입자 |
JP6454323B2 (ja) | 2013-03-15 | 2019-01-16 | パール セラピューティクス,インコーポレイテッド | 粒子状結晶性材料のコンディショニングのための方法及びシステム |
CN105324106A (zh) | 2013-04-01 | 2016-02-10 | 普马特里克斯营业公司 | 噻托铵干粉 |
SI3019153T1 (sl) * | 2013-07-11 | 2018-12-31 | Chiesi Farmaceutici S.P.A. | Formulacija suhega praška, obsegajoča antiholinergik, kortikosteroid in beta-adrenergik, za dajanje z inhalacijo |
GB201402513D0 (en) * | 2014-02-13 | 2014-04-02 | Cardiff Scintigraphics Ltd | Pressurised metered dose inhalers and method of manufacture |
US9526734B2 (en) | 2014-06-09 | 2016-12-27 | Iceutica Pty Ltd. | Formulation of meloxicam |
WO2016067252A1 (en) | 2014-10-31 | 2016-05-06 | Glaxosmithkline Intellectual Property Development Limited | Powder formulation |
MA41378A (fr) * | 2015-01-20 | 2017-11-28 | Teva Branded Pharmaceutical Prod R & D Inc | Inhalateur de poudre sèche comprenant du propionate de fluticasone et du xinafoate de salmétérol |
US10519109B2 (en) | 2015-06-15 | 2019-12-31 | Qaam Pharmaceuticals, Llc | Glycopyrronium fatty acid salts and methods of making same |
EP3844831A4 (de) * | 2018-08-30 | 2022-06-29 | Hydro-Québec | Beschichtete aktivmaterialien für wiederaufladbare lithium-ionen-batterien |
JP2021536467A (ja) | 2018-09-06 | 2021-12-27 | インノファーマスクリーン インコーポレイテッド | 喘息またはパーキンソン病の処置のための方法および組成物 |
WO2023003003A1 (ja) * | 2021-07-20 | 2023-01-26 | 興和株式会社 | 新規吸入剤 |
WO2023187393A1 (en) | 2022-03-31 | 2023-10-05 | Hovione Scientia Limited | Inhalation composite and carrier based formulation combination |
WO2023247952A1 (en) | 2022-06-21 | 2023-12-28 | Hovione Scientia Limited | Crystalline pharmaceutical composition for inhalation comprising sugar and lipid composite particles and process for manufacture |
WO2024009079A1 (en) | 2022-07-04 | 2024-01-11 | Hovione Scientia Limited | Dry powder inhaler pharmaceutical composition of coated crystalline dry powder for inhalation |
Family Cites Families (84)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1240092A (en) | 1970-01-08 | 1971-07-21 | Dynamic Tools Ltd | A swivel connector |
GB1381872A (en) | 1971-06-22 | 1975-01-29 | Fisons Ltd | Pharmaceutical compositions for inhalation |
US5192528A (en) * | 1985-05-22 | 1993-03-09 | Liposome Technology, Inc. | Corticosteroid inhalation treatment method |
IT1204826B (it) * | 1986-03-04 | 1989-03-10 | Chiesi Farma Spa | Composizioni farmaceutiche per inalazione |
WO1988001165A1 (en) | 1986-08-11 | 1988-02-25 | Innovata Biomed Limited | Pharmaceutical formulations comprising microcapsules |
US5320906A (en) * | 1986-12-15 | 1994-06-14 | Vestar, Inc. | Delivery vehicles with amphiphile-associated active ingredient |
JP2668880B2 (ja) | 1987-06-23 | 1997-10-27 | 日本油脂株式会社 | 被覆アミノ酸類の製造方法 |
US5190764A (en) | 1988-03-03 | 1993-03-02 | Hokko Chemical Industry Co., Ltd. | Agent for imparting a sustained release property to a pesticide, a pesticide having a sustained release property and a process for the production thereof |
US5223244A (en) | 1988-06-20 | 1993-06-29 | Shiseido Company, Ltd. | Aerosol composition |
US4906476A (en) * | 1988-12-14 | 1990-03-06 | Liposome Technology, Inc. | Novel liposome composition for sustained release of steroidal drugs in lungs |
EP0470154B1 (de) * | 1989-04-28 | 1996-06-05 | Riker Laboratories, Inc. | Inhalationsvorrichtung für trockenpulver |
US5188837A (en) | 1989-11-13 | 1993-02-23 | Nova Pharmaceutical Corporation | Lipsopheres for controlled delivery of substances |
US5376386A (en) | 1990-01-24 | 1994-12-27 | British Technology Group Limited | Aerosol carriers |
IL98310A (en) | 1990-06-08 | 1996-08-04 | Astra Ab | Medicinal preparations containing a history of cystine |
GB9024365D0 (en) | 1990-11-09 | 1991-01-02 | Glaxo Group Ltd | Medicaments |
US5145684A (en) | 1991-01-25 | 1992-09-08 | Sterling Drug Inc. | Surface modified drug nanoparticles |
US5413804A (en) * | 1991-04-23 | 1995-05-09 | Cacique, Inc. | Process for making whey-derived fat substitute product and products thereof |
DE4140689B4 (de) | 1991-12-10 | 2007-11-22 | Boehringer Ingelheim Kg | Inhalationspulver und Verfahren zu ihrer Herstellung |
JP2735979B2 (ja) * | 1992-04-23 | 1998-04-02 | 花王株式会社 | 樹脂粉末及び化粧料 |
ES2177544T3 (es) * | 1992-06-12 | 2002-12-16 | Teijin Ltd | Polvo ultrafinno para inhalar y metodo para su preparacion. |
GB2269992A (en) | 1992-08-14 | 1994-03-02 | Rh Ne Poulenc Rorer Limited | Powder inhalation formulations |
JPH0696517A (ja) | 1992-09-11 | 1994-04-08 | Matsushita Electric Ind Co Ltd | 磁気ディスク装置 |
SE9203743D0 (sv) * | 1992-12-11 | 1992-12-11 | Astra Ab | Efficient use |
US5672581A (en) | 1993-01-29 | 1997-09-30 | Aradigm Corporation | Method of administration of insulin |
TW402506B (en) | 1993-06-24 | 2000-08-21 | Astra Ab | Therapeutic preparation for inhalation |
US5506203C1 (en) * | 1993-06-24 | 2001-02-06 | Astra Ab | Systemic administration of a therapeutic preparation |
DE4323636A1 (de) * | 1993-07-15 | 1995-01-19 | Hoechst Ag | Arzneistoffzubereitungen aus umhüllten, schwerstwasserlöslichen Arzneistoffen für Inhalationsarzneiformen und Verfahren zu ihrer Herstellung |
US5744155A (en) | 1993-08-13 | 1998-04-28 | Friedman; Doron | Bioadhesive emulsion preparations for enhanced drug delivery |
GB9322014D0 (en) | 1993-10-26 | 1993-12-15 | Co Ordinated Drug Dev | Improvements in and relating to carrier particles for use in dry powder inhalers |
US5441753A (en) * | 1994-01-28 | 1995-08-15 | Fmc Corporation | Coprocessed particulate bulking and formulating AIDS: their composition, production, and use |
ATE264096T1 (de) * | 1994-03-07 | 2004-04-15 | Nektar Therapeutics | Verfahren und mittel zur verabreichung von insulin über die lunge |
US5711934A (en) * | 1994-04-11 | 1998-01-27 | Abbott Laboratories | Process for the continuous milling of aerosol pharmaceutical formulations in aerosol propellants |
US5647347A (en) | 1994-10-21 | 1997-07-15 | Glaxo Wellcome Inc. | Medicament carrier for dry powder inhalator |
US6103271A (en) * | 1994-12-02 | 2000-08-15 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Microencapsulation and electrostatic processing method |
MY131733A (en) * | 1994-12-22 | 2007-08-30 | Astra Ab | Aerosol drug formulations |
AR002009A1 (es) * | 1994-12-22 | 1998-01-07 | Astra Ab | Composicion farmaceutica, procedimiento para la manufactura de un polvo de proliposoma como el utilizado en dicha composicion, procedimiento para lamanufactura de dicha composicion, uso de dicha composicion farmaceutica en la manufactura de un medicamento y dispositivo inhalador de polvo seco. |
US6524557B1 (en) | 1994-12-22 | 2003-02-25 | Astrazeneca Ab | Aerosol formulations of peptides and proteins |
GB9501841D0 (en) | 1995-01-31 | 1995-03-22 | Co Ordinated Drug Dev | Improvements in and relating to carrier particles for use in dry powder inhalers |
US5612053A (en) | 1995-04-07 | 1997-03-18 | Edward Mendell Co., Inc. | Controlled release insufflation carrier for medicaments |
US5635160A (en) * | 1995-06-07 | 1997-06-03 | The University Of North Carolina At Chapel Hill | Dinucleotides useful for the treatment of cystic fibrosis and for hydrating mucus secretions |
US5931809A (en) | 1995-07-14 | 1999-08-03 | Depotech Corporation | Epidural administration of therapeutic compounds with sustained rate of release |
GB9515182D0 (en) * | 1995-07-24 | 1995-09-20 | Co Ordinated Drug Dev | Improvements in and relating to powders for use in dry powder inhalers |
SE9502799D0 (sv) | 1995-08-10 | 1995-08-10 | Astra Ab | Device in inhalers |
US5738665A (en) | 1996-09-26 | 1998-04-14 | Becton, Dickinson And Company | Shield and actuator for needles |
US7366670B1 (en) | 1997-08-05 | 2008-04-29 | At&T Corp. | Method and system for aligning natural and synthetic video to speech synthesis |
US5997846A (en) | 1997-11-17 | 1999-12-07 | Albert Einstein College Of Medicine Of Yeshiva University | Method for detecting arthropods |
US6178414B1 (en) * | 1997-12-16 | 2001-01-23 | Nortel Networks Limited | Method and apparatus for updating and searching an ordered list of values stored within a memory resource |
US6086376A (en) | 1998-01-30 | 2000-07-11 | Rtp Pharma Inc. | Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant |
US20030118514A1 (en) * | 1998-03-26 | 2003-06-26 | Glaxo Wellcome Inc. | Compositions for inhalation |
US5945123A (en) | 1998-04-02 | 1999-08-31 | K-V Pharmaceutical Company | Maximizing effectiveness of substances used to improve health and well being |
CA2328882A1 (en) | 1998-04-18 | 1999-10-28 | Glaxo Group Limited | Pharmaceutical aerosol formulation |
GT199900148A (es) * | 1998-09-10 | 2001-02-28 | Desnaturalizantes para las sales aminas simpaticomimeticas. | |
US7521068B2 (en) * | 1998-11-12 | 2009-04-21 | Elan Pharma International Ltd. | Dry powder aerosols of nanoparticulate drugs |
US20070212422A1 (en) * | 1999-11-10 | 2007-09-13 | Manfred Keller | Dry powder for inhalation |
CA2347856C (en) * | 1998-11-13 | 2009-02-17 | Jago Research Ag | Dry powder for inhalation |
US20010020242A1 (en) * | 1998-11-16 | 2001-09-06 | Amit Gupta | Method and apparatus for processing client information |
US6984404B1 (en) | 1998-11-18 | 2006-01-10 | University Of Florida Research Foundation, Inc. | Methods for preparing coated drug particles and pharmaceutical formulations thereof |
BR9915462A (pt) * | 1998-11-18 | 2001-12-11 | Univ Florida | Processos para preparação de partìculas dedroga revestidas e as suas formulaçõesfarmacêuticas |
GB9826783D0 (en) | 1998-12-04 | 1999-01-27 | Scherer Ltd R P | Inhalation powders |
GB9827145D0 (en) | 1998-12-09 | 1999-02-03 | Co Ordinated Drug Dev | Improvements in or relating to powders |
US6542490B1 (en) | 1999-01-29 | 2003-04-01 | Nortel Networks Limited | Data link control proctocol for 3G wireless system |
IT1309592B1 (it) | 1999-03-05 | 2002-01-24 | Chiesi Farma Spa | Particelle veicolo modificate da utilizzarsi nella preparazione diformulazioni farmaceutiche sotto forma di polimeri per inalazione e |
SI1158958T1 (sl) | 1999-03-05 | 2007-10-31 | Chiesi Farma Spa | Izboljĺ ani praĺ kasti farmacevtski sestavki za inhalacijo |
WO2000061108A1 (en) * | 1999-04-14 | 2000-10-19 | Glaxo Group Limited | Pharmaceutical aerosol formulation |
US6406745B1 (en) | 1999-06-07 | 2002-06-18 | Nanosphere, Inc. | Methods for coating particles and particles produced thereby |
ITMI991582A1 (it) | 1999-07-16 | 2001-01-16 | Chiesi Farma Spa | Polveri costituite da particelle aventi la superficie perfettamente levigata da utilizzare come veicoli per la preparazione di miscele inala |
US6197369B1 (en) * | 1999-09-30 | 2001-03-06 | New Jersey Institute Of Technology | Method of particle coating |
GB0008660D0 (en) | 2000-04-07 | 2000-05-31 | Arakis Ltd | The treatment of respiratory diseases |
GB0009469D0 (en) | 2000-04-17 | 2000-06-07 | Vectura Ltd | Improvements in or relating to formalities for use in inhaler devices |
GB0009468D0 (en) * | 2000-04-17 | 2000-06-07 | Vectura Ltd | Improvements in or relating to formulations for use in inhaler devices |
PE20011227A1 (es) * | 2000-04-17 | 2002-01-07 | Chiesi Farma Spa | Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros |
US7871598B1 (en) | 2000-05-10 | 2011-01-18 | Novartis Ag | Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use |
CN100551358C (zh) * | 2000-06-27 | 2009-10-21 | 维克多瑞有限公司 | 用于药物组合物的颗粒的制备方法 |
US6404772B1 (en) * | 2000-07-27 | 2002-06-11 | Symbol Technologies, Inc. | Voice and data wireless communications network and method |
HUP0302311A3 (en) | 2000-10-09 | 2006-07-28 | 3M Innovative Properties Co | Medicinal aerosol formulations |
KR100488644B1 (ko) | 2000-10-12 | 2005-05-11 | 베링거 잉겔하임 파르마 게엠베하 운트 코 카게 | 티오트로퓸을 함유하는 신규 흡입용 산제 |
ATE446085T1 (de) * | 2000-11-30 | 2009-11-15 | Vectura Ltd | Partikel zur verwendung in einer pharmazeutischen zusammensetzung |
DK1337240T4 (en) * | 2000-11-30 | 2015-01-05 | Vectura Ltd | A process for the preparation of particles for use in a pharmaceutical composition |
US20060147389A1 (en) | 2004-04-14 | 2006-07-06 | Vectura Ltd. | Devices and pharmaceutical compositions for enhancing dosing efficiency |
GB0321607D0 (en) | 2003-09-15 | 2003-10-15 | Vectura Ltd | Manufacture of pharmaceutical compositions |
EP1663164A2 (de) | 2003-09-15 | 2006-06-07 | Vectura Limited | Verfahren zur herstellung von pharmazeutischen zusammensetzungen |
GB0425758D0 (en) * | 2004-11-23 | 2004-12-22 | Vectura Ltd | Preparation of pharmaceutical compositions |
GB0426301D0 (en) * | 2004-11-30 | 2004-12-29 | Vectura Ltd | Pharmaceutical formulations |
MX2012006799A (es) * | 2009-12-14 | 2012-07-23 | Chiesi Farma Spa | Microparticulas de antibiotico para inhalacion. |
-
2001
- 2001-11-30 DK DK01998328.7T patent/DK1337240T4/en active
- 2001-11-30 PT PT01998328T patent/PT1337240E/pt unknown
- 2001-11-30 ES ES07123922.2T patent/ES2474199T3/es not_active Expired - Lifetime
- 2001-11-30 EP EP10185643.3A patent/EP2283818B1/de not_active Revoked
- 2001-11-30 DK DK07123922.2T patent/DK1920763T3/da active
- 2001-11-30 AT AT01998329T patent/ATE382335T1/de active
- 2001-11-30 EP EP10182218.7A patent/EP2298279B1/de not_active Revoked
- 2001-11-30 US US10/433,072 patent/US7736670B2/en not_active Expired - Fee Related
- 2001-11-30 ES ES10182218T patent/ES2708961T3/es not_active Expired - Lifetime
- 2001-11-30 PT PT71239222T patent/PT1920763E/pt unknown
- 2001-11-30 ES ES10181899.5T patent/ES2587135T3/es not_active Expired - Lifetime
- 2001-11-30 EP EP10183504A patent/EP2298285A3/de not_active Withdrawn
- 2001-11-30 EP EP10181899.5A patent/EP2283817B1/de not_active Revoked
- 2001-11-30 US US10/433,185 patent/US8048451B2/en not_active Expired - Fee Related
- 2001-11-30 PT PT101856433T patent/PT2283818T/pt unknown
- 2001-11-30 EP EP17184081.2A patent/EP3269360A1/de not_active Withdrawn
- 2001-11-30 AT AT01998328T patent/ATE517607T1/de active
- 2001-11-30 PT PT101818995T patent/PT2283817T/pt unknown
- 2001-11-30 DK DK10181899.5T patent/DK2283817T3/en active
- 2001-11-30 EP EP07123922.2A patent/EP1920763B2/de not_active Expired - Lifetime
-
2004
- 2004-02-09 HK HK04100843.5A patent/HK1058145A1/xx not_active IP Right Cessation
-
2009
- 2009-06-05 JP JP2009136162A patent/JP5192447B2/ja not_active Expired - Lifetime
-
2010
- 2010-04-26 US US12/767,530 patent/US8303991B2/en not_active Expired - Lifetime
-
2011
- 2011-08-15 HK HK11108528.1A patent/HK1154347A1/zh not_active IP Right Cessation
- 2011-10-07 US US13/269,025 patent/US8435567B2/en not_active Expired - Lifetime
- 2011-10-25 CY CY20111101009T patent/CY1112338T1/el unknown
-
2012
- 2012-09-20 US US13/623,326 patent/US8956661B2/en not_active Expired - Fee Related
-
2013
- 2013-03-27 US US13/851,205 patent/US8932635B2/en not_active Expired - Fee Related
-
2014
- 2014-07-01 CY CY20141100492T patent/CY1115304T1/el unknown
- 2014-11-20 US US14/548,419 patent/US10188612B2/en not_active Expired - Fee Related
- 2014-11-25 US US14/553,187 patent/US9931304B2/en not_active Expired - Fee Related
-
2016
- 2016-03-24 US US15/079,171 patent/US9962338B2/en not_active Expired - Fee Related
-
2017
- 2017-03-09 US US15/454,319 patent/US10449161B2/en not_active Expired - Fee Related
- 2017-03-13 US US15/457,420 patent/US10973771B2/en not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1154347A1 (zh) | 製備用於藥物組合物的顆粒的方法 | |
WO2002043701A3 (en) | Method of making particles for use in a pharmaceutical composition | |
WO2005025536A8 (en) | Dry powder composition comprising co-jet milled particles for pulmonary inhalation | |
DE60104399D1 (de) | Pulverformulierung zur inhalation | |
HK1056115A1 (en) | Method of making particles for use in a pharmaceutical composition | |
HUP0204136A2 (hu) | Eljárások az interleukin-2 tüdőbe juttatására | |
WO2004043363A8 (en) | Protein-stabilized liposomal formulations of pharmaceutical agents | |
WO2007090882A3 (en) | Pharmaceutical extended release compositions comprising pramipexole | |
PT1131071E (pt) | Composicoes farmaceuticas contendo nicotina dando uma absorcao por via transmucosa rapida | |
YU36302A (sh) | Novi tiotropiumski preparati - koji sadrže prah za inhaliranje | |
WO2002070438A3 (en) | Compositions for delivering bisphosphonates | |
BRPI0608791B8 (pt) | cápsulas para inaladores, uso de uma composição de polímero e processo para a secagem de pós para inalação | |
WO2005055976A3 (de) | Pulver enthaltend niedermolekulares dextran und verfahren zu deren herstellung | |
AU2002316820A1 (en) | Powder inhaler formulations | |
SE0102276D0 (sv) | Device and method for the administration of a medicament | |
BRPI0313764A2 (pt) | método de preparação de composições de inalação de pó seco | |
SE0103211D0 (sv) | New formulations and use thereof | |
ATE307553T1 (de) | Dentalkomposite aufweisend hybridfüllstoffe und verfahren zur herstellung | |
IL164440A0 (en) | New pharmaceutical composition containing fibanserin polymorph a | |
WO2003063824A3 (en) | Pharmaceutical composition | |
WO2002015880A8 (en) | Powdered mannitol and mannitol-containing compositions | |
WO2007002897A8 (en) | Compositions to improve the bioavailability of polymethoxyflavones and tocotrienols for treatment of cardiovascular disease | |
WO2002043693A3 (en) | Pharmaceutical compositions for inhalation | |
ATE474553T1 (de) | Neue pulverinhalativa auf basis modifizierter laktosemischungen als hilfsstoff | |
WO2005094893A3 (en) | Freeze-dried, free-flowing, particulate composition having improved palatability |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PE | Patent expired |
Effective date: 20211129 |